The coronavirus family member, SARS-CoV-2 has been identified as the causal agent for
the pandemic viral pneumonia disease, COVID-19. At this time, no vaccine is available to …

Background A vaccine against SARS-CoV-2 is of high urgency. Here the safety and
immunogenicity induced by a DNA vaccine (INO-4800) targeting the full length spike antigen of …

Despite the development of highly effective prophylactic vaccines against human papillomavirus
(HPV) serotypes 16 and 18, prevention of cervical dysplasia and cancer in women …

First identified in 2012, Middle East respiratory syndrome (MERS) is caused by an emerging
human coronavirus, which is distinct from the severe acute respiratory syndrome …

Significant concerns have been raised owing to the rapid global spread of infection and
disease caused by the mosquito-borne Zika virus (ZIKV). Recent studies suggest that ZIKV can …

Chikungunya virus (CHIKV) is an emerging mosquito-borne alphavirus indigenous to tropical
Africa and Asia. Acute illness is characterized by fever, arthralgias, conjunctivitis, rash, and …

West Nile virus (WNV) is a member of the Flaviviridae family of vector-borne pathogens.
Clinical signs of WNV infection include neurologic symptoms, limb weakness, and encephalitis, …

DNA vaccines are a promising technology for the induction of Ag-specific immune responses,
and much recent attention has gone into improving their immune potency. In this study we …

Zika virus (ZIKV) is an emerging pathogen causally associated with serious sequelae in
fetuses, inducing fetal microcephaly and other neurodevelopment defects. ZIKV is primarily …

Background. Vaccination and passive antibody therapies are critical for controlling infectious
diseases. Passive antibody administration has limitations, including the necessity for …